These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27245498)

  • 1. Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?
    Albert-Vartanian A; Boyd MR; Hall AL; Morgado SJ; Nguyen E; Nguyen VP; Patel SP; Russo LJ; Shao AJ; Raffa RB
    J Clin Pharm Ther; 2016 Aug; 41(4):371-82. PubMed ID: 27245498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-addictive orally-active kappa opioid agonists for the treatment of peripheral pain in rats.
    Beck TC; Reichel CM; Helke KL; Bhadsavle SS; Dix TA
    Eur J Pharmacol; 2019 Aug; 856():172396. PubMed ID: 31103632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse.
    Schaefer CP; Tome ME; Davis TP
    Fluids Barriers CNS; 2017 Nov; 14(1):32. PubMed ID: 29183383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa opioids as potential treatments for stimulant dependence.
    Prisinzano TE; Tidgewell K; Harding WW
    AAPS J; 2005 Oct; 7(3):E592-9. PubMed ID: 16353938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential therapeutic targets for the treatment of opioid abuse and pain.
    Kiguchi N; Ko MC
    Adv Pharmacol; 2022; 93():335-371. PubMed ID: 35341570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Plant to Chemistry: Sources of Active Opioid Antinociceptive Principles for Medicinal Chemistry and Drug Design.
    Turnaturi R; Piana S; Spoto S; Costanzo G; Reina L; Pasquinucci L; Parenti C
    Molecules; 2023 Oct; 28(20):. PubMed ID: 37894567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.
    Fishbane S; Jamal A; Munera C; Wen W; Menzaghi F;
    N Engl J Med; 2020 Jan; 382(3):222-232. PubMed ID: 31702883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of difelikefalin as a treatment option for moderate-to-severe pruritus in end stage renal disease.
    Lipman ZM; Yosipovitch G
    Expert Opin Pharmacother; 2021 Apr; 22(5):549-555. PubMed ID: 33190563
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients.
    Fishbane S; Mathur V; Germain MJ; Shirazian S; Bhaduri S; Munera C; Spencer RH; Menzaghi F;
    Kidney Int Rep; 2020 May; 5(5):600-610. PubMed ID: 32405581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Effectiveness and Safety of Oxycodone Hydrochloride and Fentanyl for Post-operative Pain Following Total Hip Arthroplasty: A Randomized Triple-Blind Trial.
    Kohaf N; Harby SA; Abd-Ellatief AF; Elsaid MA; Abdelmottaleb NA; Abd Elsalam TF
    Anesth Pain Med; 2024 Feb; 14(1):e142710. PubMed ID: 38725916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro and In Vivo Pharmacological Profiles of LENART01, a Dermorphin-Ranatensin Hybrid Peptide.
    Hochrainer N; Serafin P; D'Ingiullo S; Mollica A; Granica S; Brytan M; Kleczkowska P; Spetea M
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel kappa opioid receptor agonist ZYKR1: a randomized double-blind placebo-control phase 1 study in healthy adult human participants.
    Kansagra KA; Momin T; Patel HB; Shah C; Parmar G; Ghoghari A; Patel HV; Parmar DV
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4737-4745. PubMed ID: 38141084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness of HSK21542 for hemodialysis patients: a multiple ascending dose study.
    Pan M; Wang G; Zhou L; Xu Y; Yao L; Wu C; Mei C; Zhao Z; Sun D; Guan T; Chen Q; Shi M; Xu H; Zeng W; Li F; Yan R; Liu BC
    Front Pharmacol; 2023; 14():1203642. PubMed ID: 37876731
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a Selective Peptide κ-Opioid Receptor Antagonist by Late-Stage Functionalization with Cysteine Staples.
    Muratspahić E; White AM; Ciotu CI; Hochrainer N; Tomašević N; Koehbach J; Lewis RJ; Spetea M; Fischer MJM; Craik DJ; Gruber CW
    J Med Chem; 2023 Sep; 66(17):11843-11854. PubMed ID: 37632447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Utility of Peripherally Restricted Kappa-Opioid Receptor Agonists for Inhibiting Below-Level Pain After Spinal Cord Injury in Mice.
    Ma D; Huang Q; Gao X; Ford NC; Guo R; Zhang C; Liu S; He SQ; Raja SN; Guan Y
    Neuroscience; 2023 Sep; 527():92-102. PubMed ID: 37516437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, Metabolism, and Excretion of Intravenous [14C]Difelikefalin in Healthy Subjects and Subjects on Hemodialysis.
    Stark JG; Noonan PK; Spencer RH; Bhaduri S; O'Connor SJ; Menzaghi F
    Clin Pharmacokinet; 2023 Sep; 62(9):1231-1241. PubMed ID: 37369955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the physical dependence potential of difelikefalin: Randomized placebo-controlled study in patients receiving hemodialysis.
    Spencer RH; Munera C; Shram MJ; Menzaghi F
    Clin Transl Sci; 2023 Sep; 16(9):1559-1568. PubMed ID: 37128642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Downregulation of Opioid Receptors and Neuropathic Pain.
    Li L; Chen J; Li YQ
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solving an Old Puzzle: Elucidation and Evaluation of the Binding Mode of Salvinorin A at the Kappa Opioid Receptor.
    Puls K; Wolber G
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677775
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.